Kojak Selinge is outcome of the effort between STAR Syringes of U.K & HMD. HMD collaborated with STAR Syringes of U.K., since their technology was innovative, advanced, simple and affordable. It definitely reflects HMDs endeavour to mass-produce value for money products. STAR Syringes own the international patent of the design, which has won the International Millennium Product Design Award of 1999 and the Design Effectiveness Award of 2000 ,the prestigious United Kingdoms Queens Award and meets ISO 7886-3 & ISO7886-4 Standards for A.D. Syringes.
Product category: Syringes, Insulin syringes and injectors
DispoVan & Unolok insulin syringes are manufactured on totally automated printing, assembly and packaging lines as per the requirements of the most stringent quality standards. 31G x 5/16″, Super-fine 30Gx5/16″ Xtra-fine 29Gx1/2″ needles are siliconised to give minimal pain. Presence of low dead space avoids wastage of medication and ensures accurate dosage. For people who take very small doses (such as children) twice, accuracy of dosage is there in 0.5 ml. Dispovan & Unolok insulin syringes, due to scale increments of 1 unit as compared to 2 units in 1 ml U 100 syringe.
IV Cannulas are placed inside a vein to provide venous access. Venous access allows sampling of blood, as well as administration of fluids, medications, parenteral nutrition, chemotherapy, and blood products
Product category: Waste management devices for disposable products
The safety box is designed for safe disposal of medical sharps and needles which may otherwise result in injuries. The safety box is one of the most innovatively designed products by HMD healthcare and is a highly sought after medical consumable.
Manufactured using premium-quality cold-rolled stainless steel strips with the latest Japanese technology; Dispovan and Unolok needles are ground on high-precision machines: assembled and packed on totally automated machines. Vision cameras ensure 100% automated quality control, enabling superior sharpness to minimize pain.
Product category: Disposable laboratory material made of plastic
Evacuated (Vacuum) tube
HMDs uniquely designed Evacuated (Vacuum) tube systems helps make the venepuncture procedures simpler by allowing blood to be collected directly into the tube. The products are a part of a closed system unlike other open systems which involve collection of blood into a syringe and then transferring them into test tubes.
HMD, founded in 1957 and formally inaugurated on 4th Jan. 1959 was created to serve the medical profession with affordable ,world class medical devices. It was the very first Technical Collaboration between a Japanese Corporation and an Indian MSME to produce glass syringes.
HMD is the first company in the world to launch a comprehensive range of sizes of Auto Disable Syringes for curative segment, in the world.
Date – 4th Jan 1959 HMD started with manufacturing of Glass Syringes in the year 1959 and subsequently added other products such as Surgical Blades in 1971 , Single Use Syringes in 1986, Single use needle in 1987, Cannula manufacturing in 1989, Scalpvein Infusion Sets in 1991, I.V Cannulas in 1992 , Auto Disable Syringes in 2001 , Vacuum Blood Collection Tubes in 2007, Blood Collection Needles in 2008 and safety I.V Cannulas in 2014 to its product range.
Date – 4th Jan 1959 To cater to its commitment effectively of providing Safe Injections, few years back HMD wasted no time in coming-up with State-of-the-Art manufacturing facility, specifically for manufacturing K1 Design Auto Disable Syringes, for which HMD technologically collaborated with M/s.Star Syringe UK.
HMD has always been at the fore front in serving the medical fraternity by regularly adding new products to its product range. HMD has collaboration with M/s.Ester Technology, Israel and launched Vaku-8 brand of Evacuated Blood Collection Tubes and Blood Collection Needles, which are fast getting acceptance & support of the medical fraternity.
HMD recently signed an Agreement with Swedish Medical Technology Company, where Vigmed grants HMD the right to utilize Vigmed patents on non integrated Safety I.V.Catheters and market these products under HMDs brand in a selected markets.
The new plant is spread on an area of 5.5 acres and will have the capacity to initially produce 36 million units of safety IV cannula to meet the rising export demand to Europe which is expected to be around over 50% and balance for domestic demand for its new revolutionary technology, designed to present needle-stick injuries which is very common among health workers and nursing staff.
With the advent of new year, HMD reiterates its global vision and long term goal of becoming Top5 in each of its business segments & building a unique competitive advantage in key businesses.